MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 93957-55-2
MCE 国际站:Fluvastatin sodium
产品活性:Fluvastatin sodium (XU 62320) 是第一个完全合成的,竞争性的 HMG-CoA 还原酶 抑制剂,IC50 为 8 nM。Fluvastatin sodium 通过依赖 Nrf2 的抗氧化通路保护血管平滑肌细胞免受氧化应激。
研究领域:Metabolic Enzyme/Protease | Autophagy | Apoptosis
作用靶点:HMG-CoA Reductase (HMGCR) | Autophagy | Ferroptosis
In Vitro: Fluvastatin sodium (XU 62320) is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), the enzyme that catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Human hepatocellular carcinoma cell (HCC) studies indicate that Fluvastatin induces G2/M phase arrest. In the presence of Fluvastatin (XU 62320), HCC cells show a decrease of Bcl-2 and procaspase-9 expression, and an increase in Bax, cleaved caspase-3, and cytochrome c. Fluvastatin (XU 62320) is antilipemic and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Apoptosis Compound Library | Metabolism/Protease Compound Library | NF-κB Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Antioxidant Compound Library | Oxygen Sensing Compound Library | Anti-Cardiovascular Disease Compound Library | Ferroptosis Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Lipid Metabolism Compound Library | Rare Diseases Drug Library | Children’s Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Off-patent Drug Library | Sorafenib-d4 | Lapatinib ditosylate | Ciclopirox olamine | Curcumin | L-Glutamine-d5 | HDAC-IN-48 | (S)-L-Cystine-15N2 | SR12813 | L-Glutamine-13C5,15N2 | Lapatinib-d7 dihydrochloride | Sorafenib Tosylate | Deferiprone | Cycloheximide | Pravastatin sodium | YL-939 | (-)-Epicatechin | Dopamine-d5 hydrochloride | Linagliptin-d4 | Acetylcysteine-d3 | Dopamine hydrochloride | (E)-Ferulic acid | β-Amyrin palmitate | PD146176 | Pifithrin-β hydrobromide | Pseudolaric Acid B | Lovastatin hydroxy acid sodium | L-Glutamic acid-d5 | Roxadustat | L-669,262
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
货号: HY-14664A
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。